Cancer Villages

Interesting article from The Guardian about "cancer villages" in China - places where the priority is economic gain, not public health.

Medical experimentation on detainees?

Watch the video here.

The NIH gets tough on ethics? Not likely.

In public, NIH director Tom Insel has come down hard on conflicts of interest. In private, he has been working behind the scenes to help a major violator, Charles Nemeroff, find a new plum position at the University of Miami, assuring Miami that the NIH is behind him. The story is reported by the Chronicle of Higher Education. The incriminating emails can be seen here, along with commentary by Ed Silverman of Pharmalot.

Not reading the signs

Since 2005, thousands of echocardiograms have gone unread by doctors at the Harlem Hospital Center. An ongoing investigation is looking into what exactly went wrong, and who may have been denied necessary care at the hospital. Click here to read more.

Glucose Tattoos

Researchers at MIT are developing a "glucose tattoo" - a continuous blood sugar monitor that makes use of fluorescent carbon nanotubes (in the form of nanoparticle ink) placed under the skin to reflect infrared light back through the skin and to the monitor. They say the monitor itself will be watch-sized or smaller and could eliminate the need for daily finger pricking that many diabetics have to do. Check out the article here.

Social Media to Kick Smoking

I live about 7 miles away from Philip Morris USA's corporate headquarters at the moment. Needless to say, smoking seems to be a rather popular pastime around here. Here is a CNN link on using social media / web-based smoking cessation programs. Richmond could definitely use a few of them.

Shocked but not urinating

The Strib pimps a weird new treatment for overactive bladder in this article, which reads like a press release for a local company called Uroplasty Inc. Apparently if you attach electrodes to your leg every week for three months at $25o a pop, you will have to pee less often. Read the electrifying news here.

Binge drinking is good for you

Good Old Dr. Wakefield.

Autism extraordinaire Andrew Wakefield tried to link the MMR vaccine to Crohn's Disease before his theory tying autism to that same vaccine. Check out this article from Slate.

Poppies. Poppies will put them to sleep...

Why are American soldiers trying to eradicate opium production in Afghanistan while the pharmaceutical industry is paying farmers to produce it? Read here.

Hijacked Research

A friend of mine, Dr. Gary Remafedi, has recently been the subject of malign efforts by an anti-gay group who have incorrectly referenced his research for their agenda. Click here to read more.

Are blockbusters dead?

"How bad is big pharma doing? It's been four years since anybody has launched a mass-market medicine." Read more from Matthew Herper at Forbes.com

Should the Nigerian Trovan lawsuit against Pfizer proceed?

The U.S. Solicitor General says yes. Read more at Pharmalot.

Dieting for Dollars

More employers are offering financial incentives to their workers to lose weight. MSNBC reports.

Not Another Weight Loss Show

Greetings from Richmond, VA, where I am living/working this summer. Here is an article about this new NBC show called "Losing It" which is hosted by Jillian Michaels, who was also involved with "The Biggest Loser." I haven't seen it yet, so all I can say is Yikes!

Nothing to disclose at the APA

"New Orleans. It was 95 degrees with 99 percent humidity. The Gulf had the biggest oil spill in US history. And attendees to this week's American Psychiatric Convention (APA) annual meeting in New Orleans had to brave 200 protesters chanting 'no drugging kids for money' and 'no conflicts of interest' to get into the convention hall."

Martha Rosenberg reports on the annual APA meeting. And Daniel Carlat comments here.

Hastings Center Report call for papers

"To mark the fortieth anniversary of the Hastings Center Report, we are looking forward. Rather than commemorate the issues and authors that the Report has published in the past, we want to know from you what issues bioethics should be looking at in the future!"

Gregory E. Kaebnick, editor of the Hastings Center Report, is looking to the next generation for these answers. "We'll throw the doors open: we'll read anything that any student, graduate fellow, or untenured professor in bioethics sends us (current or former Center staff excluded), and we'll publish the best of the lot in the November-December 2010 issue."

Read more here.

Conference: The Role of Narrative in Science and Medicine

"Hiram College's Center for Literature, Medicine and Biomedical Humanities celebrates its 20th anniversary and its founders, Dr. Carol Donley and Dr. Martin Kohn. Join us for two days of discussion, writing workshops, entertainment, and lectures from Rita Charon, Richard Preston and more." Read more here.

But will they FedEx your pizza?

Are telemarketers the new drug reps? Maybe so, says Astra Zeneca.

What did they know and when did they know it?

Physicians at the University of Wisconsin School of Medicine and Public Health authored papers showing that the Sanofi-Aventis drug Multaq is an excellent treatment for atrial fibrillation. Now, however, it appears that Multaq may be dangerous, and the authors apparently never saw the raw data that they vouched for. They did get large checks from Sanofi-Aventis, though. Read more in the Milwaukee Journal-Sentinel.